Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA
Adolescent
Adult
Blood Glucose
/ drug effects
Blood Glucose Self-Monitoring
/ instrumentation
Calibration
Cohort Studies
Computer Systems
/ standards
Cross-Over Studies
Diabetes Mellitus, Type 1
/ blood
Female
Glycated Hemoglobin
/ analysis
Glycemic Control
/ instrumentation
Humans
Insulin
/ administration & dosage
Insulin Infusion Systems
/ standards
Male
Patient Care Planning
Time Factors
United Kingdom
/ epidemiology
Young Adult
Journal
Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975
Informations de publication
Date de publication:
10 2020
10 2020
Historique:
received:
04
04
2020
accepted:
29
06
2020
pubmed:
30
7
2020
medline:
29
5
2021
entrez:
30
7
2020
Statut:
ppublish
Résumé
International type 1 diabetes registries have shown that HbA We conducted a randomized crossover trial in young people with type 1 diabetes (16-24 years old) comparing the Dexcom G6 CGM system and self-monitoring of blood glucose (SMBG). Participants were assigned to the interventions in random order during two 8-week study periods. During SMBG, blinded continuous glucose monitoring (CGM) was worn by each participant for 10 days at the start, week 4, and week 7 of the control period. HbA Time in range was significantly higher during CGM compared with control (35.7 ± 13.5% vs. 24.6 ± 9.3%; mean difference 11.1% [95% CI 7.0-15.2]; CGM use in young people with type 1 diabetes improves time in target and HbA
Identifiants
pubmed: 32723843
pii: dc20-0736
doi: 10.2337/dc20-0736
doi:
Substances chimiques
Blood Glucose
0
Glycated Hemoglobin A
0
Insulin
0
hemoglobin A1c protein, human
0
Banques de données
figshare
['10.2337/figshare.12616208']
ClinicalTrials.gov
['NCT03445377']
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2537-2543Informations de copyright
© 2020 by the American Diabetes Association.